Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

White hairs often regrow in alopecia areata patches.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Stephen Rothman made important discoveries in dermatology, including the use of PABA in sunscreens, but never profited from his work.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Intramuscular corticosteroids are effective and safe for severe alopecia areata, with most patients regrowing hair, but nearly half may relapse.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

No treatment works for everyone, and emotional support is crucial.

Vitiligo causes white skin patches and can lead to psychological stress.

Methotrexate, resveratrol, and curcumin may help treat alopecia areata by targeting immune cells.

PPARα agonists may help treat alopecia areata by reducing inflammation.

Frontal Fibrosing Alopecia needs better diagnostics and treatments, with dutasteride showing promise.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

New cytokine-targeted therapies show promise for treating alopecia areata.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Better hair loss models needed for research.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Children's hair loss can be caused by various factors and should be treated with appropriate, age-specific methods and psychological support.

Upadacitinib effectively treats psoriasis and lichen planus together.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

Alopecia can often be managed effectively with various treatments, but early diagnosis is crucial for preventing permanent hair loss.

STS01 1% effectively promotes hair regrowth with minimal side effects.